132 related articles for article (PubMed ID: 38079346)
21. Repetitive transcranial magnetic stimulation is efficacious as an add-on to pharmacological therapy in complex regional pain syndrome (CRPS) type I.
Picarelli H; Teixeira MJ; de Andrade DC; Myczkowski ML; Luvisotto TB; Yeng LT; Fonoff ET; Pridmore S; Marcolin MA
J Pain; 2010 Nov; 11(11):1203-10. PubMed ID: 20430702
[TBL] [Abstract][Full Text] [Related]
22. Interaction of hyperalgesia and sensory loss in complex regional pain syndrome type I (CRPS I).
Huge V; Lauchart M; Förderreuther S; Kaufhold W; Valet M; Azad SC; Beyer A; Magerl W
PLoS One; 2008 Jul; 3(7):e2742. PubMed ID: 18648647
[TBL] [Abstract][Full Text] [Related]
23. Do psychological factors influence recovery from complex regional pain syndrome type 1? A prospective study.
Bean DJ; Johnson MH; Heiss-Dunlop W; Lee AC; Kydd RR
Pain; 2015 Nov; 156(11):2310-2318. PubMed ID: 26133727
[TBL] [Abstract][Full Text] [Related]
24. Complex Regional Pain Syndrome Type 1: Diagnosis and Management.
Lee JW; Lee SK; Choy WS
J Hand Surg Asian Pac Vol; 2018 Mar; 23(1):1-10. PubMed ID: 29409405
[TBL] [Abstract][Full Text] [Related]
25. Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study.
Varenna M; Gatti D; Zucchi F; Crotti C; Braga V; Iolascon G; Frediani B; Nannipieri F; Rossini M
Ther Adv Musculoskelet Dis; 2022; 14():1759720X221142274. PubMed ID: 36569491
[TBL] [Abstract][Full Text] [Related]
26. Biphosphonates for the therapy of complex regional pain syndrome I--systematic review.
Brunner F; Schmid A; Kissling R; Held U; Bachmann LM
Eur J Pain; 2009 Jan; 13(1):17-21. PubMed ID: 18440845
[TBL] [Abstract][Full Text] [Related]
27. Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study.
Sandroni P; Benrud-Larson LM; McClelland RL; Low PA
Pain; 2003 May; 103(1-2):199-207. PubMed ID: 12749974
[TBL] [Abstract][Full Text] [Related]
28. Antiallodynic effect through spinal endothelin-B receptor antagonism in rat models of complex regional pain syndrome.
Kim YO; Kim IJ; Yoon MH
Neurosci Lett; 2015 Jan; 584():45-9. PubMed ID: 25451723
[TBL] [Abstract][Full Text] [Related]
29. Factors Associated With Disability and Sick Leave in Early Complex Regional Pain Syndrome Type-1.
Bean DJ; Johnson MH; Heiss-Dunlop W; Kydd RR
Clin J Pain; 2016 Feb; 32(2):130-8. PubMed ID: 25803756
[TBL] [Abstract][Full Text] [Related]
30. Bisphosphonates for treatment of Complex Regional Pain Syndrome type 1: A systematic literature review and meta-analysis of randomized controlled trials versus placebo.
Chevreau M; Romand X; Gaudin P; Juvin R; Baillet A
Joint Bone Spine; 2017 Jul; 84(4):393-399. PubMed ID: 28408275
[TBL] [Abstract][Full Text] [Related]
31. [Complex regional pain syndrome I and II. What effects the outcome?].
Gehling M; Tryba M; Niebergall H; Hufschmidt A; Schild M; Geiger K
Schmerz; 2003 Oct; 17(5):309-16. PubMed ID: 14513337
[TBL] [Abstract][Full Text] [Related]
32. Factors associated with complex regional pain syndrome type I in patients with surgically treated distal radius fracture.
Roh YH; Lee BK; Noh JH; Baek JR; Oh JH; Gong HS; Baek GH
Arch Orthop Trauma Surg; 2014 Dec; 134(12):1775-81. PubMed ID: 25311113
[TBL] [Abstract][Full Text] [Related]
33. Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study.
Varenna M; Braga V; Gatti D; Iolascon G; Frediani B; Zucchi F; Crotti C; Nannipieri F; Rossini M
Ther Adv Musculoskelet Dis; 2021; 13():1759720X211014020. PubMed ID: 34178124
[TBL] [Abstract][Full Text] [Related]
34. Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379].
van de Vusse AC; Stomp-van den Berg SG; Kessels AH; Weber WE
BMC Neurol; 2004 Sep; 4():13. PubMed ID: 15453912
[TBL] [Abstract][Full Text] [Related]
35. Practical management of complex regional pain syndrome.
Hsu ES
Am J Ther; 2009; 16(2):147-54. PubMed ID: 19300041
[TBL] [Abstract][Full Text] [Related]
36. A Novel Compound Analgesic Cream (Ketamine, Pentoxifylline, Clonidine, DMSO) for Complex Regional Pain Syndrome Patients.
Russo MA; Santarelli DM
Pain Pract; 2016 Jan; 16(1):E14-20. PubMed ID: 26547813
[TBL] [Abstract][Full Text] [Related]
37. Complex regional pain syndrome I (CRPS I): prospective study and laboratory evaluation.
Sandroni P; Low PA; Ferrer T; Opfer-Gehrking TL; Willner CL; Wilson PR
Clin J Pain; 1998 Dec; 14(4):282-9. PubMed ID: 9874005
[TBL] [Abstract][Full Text] [Related]
38. Lenalidomide for complex regional pain syndrome type 1: lack of efficacy in a phase II randomized study.
Manning DC; Alexander G; Arezzo JC; Cooper A; Harden RN; Oaklander AL; Raja SN; Rauck R; Schwartzman R
J Pain; 2014 Dec; 15(12):1366-76. PubMed ID: 25283471
[TBL] [Abstract][Full Text] [Related]
39. Impairments as measured by ISS do not greatly change between one and eight years after CRPS 1 diagnosis.
Vaneker M; Wilder-Smith OH; Schrombges P; Oerlemans HM
Eur J Pain; 2006 Oct; 10(7):639-44. PubMed ID: 16300975
[TBL] [Abstract][Full Text] [Related]
40. Complex regional pain syndrome (reflex sympathetic dystrophy and causalgia): management with the calcium channel blocker nifedipine and/or the alpha-sympathetic blocker phenoxybenzamine in 59 patients.
Muizelaar JP; Kleyer M; Hertogs IA; DeLange DC
Clin Neurol Neurosurg; 1997 Feb; 99(1):26-30. PubMed ID: 9107464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
